InsiderTrades

Form 4 for CTKB Cytek Biosciences, Inc.

Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-20 · accession 0001415889-24-004899 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-22 2024-02-20 CTKB Yan Ming CTO, Dir M - OptEx — +1,981 6.04M +0.0% —
D 2024-02-22 2024-02-20 CTKB Yan Ming CTO, Dir F - Tax $8.38 -588 6.04M -0.0% -$4,927
D 2024-02-22 2024-02-20 CTKB Yan Ming CTO, Dir M - OptEx $0.00 -1,981 15.2K -12% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-20 M A 1,981 — 6,044,084 D — — (F1) Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
2 Common Common Stock 2024-02-20 F D 588 $8.38 6,043,496 D — — (F2) Represents the number of shares withheld by and surrendered to the Issuer on February 20, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
3 Derivative Restricted Stock Units 2024-02-20 M D 1,981 $0.00 15,199 D — · — to — 1,981 Common Stock (F1) Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock. (F3) The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18.